Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Anaesthesiol ; 9(1): 49-53, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1310464

RESUMO

The neuromuscular and cardiovascular effects of three different doses of pipecuronium were studied in 60 adult patients. Neuromuscular blockade was measured using electromyographic activity of the adductor pollicis muscle after supramaximal stimulation of the ulnar nerve at 0.1 Hz and 2 Hz. Three subgroups (A, B, C) of 20 patients received pipecuronium doses of 60, 80 and 100 micrograms kg-1, respectively, as an intubating dose and, when necessary, maintenance doses were administered at 25% single twitch recovery in a dose of one-quarter of the initial one. The onset time was 5.4 +/- 2.0 min for 60 micrograms kg-1 and similar for 80 and 100 micrograms kg-1 (3.9 +/- 1.1 and 3.6 +/- 1.1 min). The duration of action was 45 +/- 10 min for 60 micrograms kg-1, 74 +/- 25 and 94 +/- 21 for 80 and 100 micrograms kg-1, respectively. The recovery indices were measured in all patients after neostigmine administration (Groups B and C) and after neostigmine and edrophonium (Subgroup A, 10 patients each). TOF ratio was significant only 2 min after edrophonium administration in Group A patients. Variations of heart rate and blood pressure were not significant.


Assuntos
Androstano-3,17-diol/análogos & derivados , Anestesia Geral , Hemodinâmica/efeitos dos fármacos , Bloqueadores Neuromusculares/administração & dosagem , Junção Neuromuscular/efeitos dos fármacos , Piperazinas/administração & dosagem , Adulto , Androstano-3,17-diol/administração & dosagem , Androstano-3,17-diol/farmacologia , Feminino , Fentanila , Humanos , Masculino , Pessoa de Meia-Idade , Bloqueadores Neuromusculares/farmacologia , Óxido Nitroso , Pipecurônio , Piperazinas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...